Everything you need to know about gallbladder cancer, including why North India — and Delhi specifically — has one of the highest incidence rates in the world, explained clearly by Dr. Aditya Sarin.
This page is for informational purposes only and does not constitute medical advice, diagnosis or treatment. Every case of gallbladder cancer is different. Please consult Dr Aditya Sarin or a qualified oncologist for evaluation, diagnosis and a treatment plan specific to your condition.
Persistent abdominal pain, jaundice, or unexplained weight loss should never be dismissed as routine gallstones. Schedule an evaluation with Dr. Aditya Sarin today.
Gallbladder cancer begins in the gallbladder — a small, pear-shaped organ beneath the liver that stores bile used to digest fat. It is an uncommon cancer globally, but it has an unusually concentrated geographic distribution, and North India is one of the highest-incidence regions anywhere in the world.
Gallbladder cancer is notoriously difficult to catch early. It often causes no specific symptoms until it has already spread beyond the gallbladder, and it is frequently discovered incidentally during surgery for gallstones or another unrelated condition.
Gallbladder cancer has one of the most striking geographic patterns of any cancer, and nowhere is this more visible than in North India, where incidence rates rival or exceed the highest reported anywhere in the world.
Delhi's age-adjusted female incidence rate of 21.5 per 100,000 is the highest recorded in the world, ahead of Karachi (13.8) and Quito (12.9).
Incidence in the north is roughly ten times higher than in the south — 8.9 per 100,000 in Delhi, compared with just 0.8 per 100,000 in Chennai.
The highest-risk regions lie along the Ganges river basin, particularly eastern Uttar Pradesh and western Bihar, downstream of a river linked to heavy metal and pesticide contamination.
The average age at diagnosis in India is around 51 years, compared with roughly 71 years in the West — a difference not yet fully explained.
Gallbladder cancer often causes no specific symptoms in its early stages, which is a major reason it is so frequently diagnosed late. When symptoms do appear, they are often mistaken for gallstones or other digestive issues.
Note: Because these symptoms overlap so heavily with common gallstone disease, persistent or worsening symptoms — especially jaundice — should prompt thorough evaluation rather than being dismissed as routine digestive trouble.
The exact cause of gallbladder cancer is not fully understood, but several factors are known to increase risk, some of which are unusually pronounced in North India specifically.
Present in around 80% of Indian gallbladder cancer patients, though cancer incidence is disproportionate to gallstone prevalence alone.
Long-standing inflammation, including from chronic Salmonella typhi infection, is linked to increased risk.
Women are affected two to three times more often than men, and risk rises with age, though the average diagnosis age in India is notably younger.
Studies in high-incidence regions of Bihar have linked arsenic and heavy metal exposure, particularly through contaminated water, to elevated risk.
Obesity and certain dietary patterns are associated with increased risk, likely partly through their link to gallstone formation.
Having one or more risk factors does not mean a person will develop gallbladder cancer, but the combination of high gallstone prevalence and environmental exposure in parts of North India substantially raises population-level risk.
There is no routine population-wide screening test for gallbladder cancer. Early detection depends on recognising symptoms, evaluating gallstones appropriately, and, in a meaningful share of cases, incidental discovery during gallbladder surgery for another reason.
Often the first imaging test, and how a meaningful share of gallbladder cancers are first suspected.
Detailed imaging to assess the extent of the tumour and whether it has spread to the liver or nearby structures.
Liver function tests and tumour markers such as CA 19-9 can support diagnosis, though none are specific enough alone.
Many gallbladder cancers are confirmed only after the gallbladder is removed and examined by a pathologist.
In a high-incidence region like North India, any unusual gallbladder finding on ultrasound, or persistent symptoms in someone with known gallstones, deserves careful evaluation rather than routine dismissal.
Staging describes how far the cancer has spread and directly determines whether surgery can be curative. Gallbladder cancer is staged using the AJCC TNM system, based on how deeply the tumour has grown into the gallbladder wall, lymph node involvement, and distant spread. This staging guidance is current as of 2026.
Source: American Cancer Society, Gallbladder Cancer Staging.
Survival statistics are population averages. They describe outcomes across large groups of patients and do not predict what will happen to any individual patient.
Source: Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Centre, Kolkata 2017–2019, Cancer Medicine, 2023, based on 698 confirmed cases.
The gap between India's early and late-stage outcomes is dramatic and underscores why recognising symptoms early and evaluating gallstones thoroughly matters enormously in high-incidence regions like North India.
Treatment depends heavily on whether the cancer is caught early enough for surgery to be curative. Dr. Aditya Sarin develops a comprehensive, personalised treatment plan for every patient, working as part of a multidisciplinary team.
Surgical removal of the gallbladder along with a margin of liver tissue and nearby lymph nodes — the only potentially curative treatment for earlier-stage disease.
Removal of the gallbladder alone, sometimes performed for gallstones before cancer is discovered incidentally on pathology.
Used both after surgery to reduce recurrence risk and as the primary treatment for unresectable or metastatic disease.
Checkpoint inhibitors added to standard chemotherapy are now part of the standard treatment approach for advanced, unresectable biliary tract cancers.
Used selectively, often alongside chemotherapy, for locally advanced disease.
An option for select patients whose tumours carry specific genetic alterations identified through molecular testing.
Stenting or drainage procedures to relieve jaundice and improve quality of life when the bile duct is blocked by tumour.
The most significant recent shift in gallbladder and biliary tract cancer treatment has been the addition of immunotherapy to standard chemotherapy for advanced disease, which is now firmly established as the current standard of care.
Durvalumab plus chemotherapy was approved by the FDA in September 2022, and pembrolizumab plus chemotherapy followed in October 2023, both for unresectable or metastatic biliary tract cancer, a category that includes gallbladder cancer. In the pivotal TOPAZ-1 trial, median overall survival improved to 12.8 months with durvalumab versus 11.5 months with chemotherapy alone, and roughly one in four patients on durvalumab were still alive at two years, compared with about one in ten on chemotherapy alone.
Source: FDA Approval Summary, Durvalumab and Pembrolizumab — Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer, Clinical Cancer Research, 2024.
A gallbladder cancer diagnosis, and the surgery it often requires, affects digestion and daily life in ways that need practical, ongoing support alongside cancer treatment itself.
Dietary guidance to manage digestion after gallbladder removal and support strength during treatment.
Professional emotional support and peer groups for patients and families navigating a diagnosis that often comes without warning.
Coordinated care for pain, jaundice, and other symptoms that can arise from more advanced disease.
ESMO Board Certified · Harvard Trained · Sir Ganga Ram Hospital, New Delhi
ESMO Board Certified oncologist with advanced training in precision oncology and cancer genomics from Harvard Medical School, practising in one of the world's highest-incidence regions for this cancer.
Access to the latest immunotherapy combinations, molecular testing, and personalised treatment protocols tailored to your specific stage and resectability.
Personalised treatment plans, nutritional guidance, emotional counselling, and end-to-end support for patients and families.
High-quality oncology care with insurance assistance, flexible appointment options, and both in-person and remote consultations.
Don't assume it's "just gallstones" — persistent pain deserves a second look, especially here in North India. If you've noticed persistent abdominal pain, jaundice, or simply want expert guidance given a history of gallstones, speak with Dr. Aditya Sarin — a trusted gallbladder cancer specialist in New Delhi.
📅 Book Your Consultation